• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX 15 HOLLOW FIBER OXYGENATOR AF; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX 15 HOLLOW FIBER OXYGENATOR AF; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number 1ZZ*FX15EA
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/12/2018
Event Type  malfunction  
Manufacturer Narrative
Patient identifier - requested, not provided.Age and date of birth - requested, not provided/ sex - requested, not provided.Weight - requested, not provided.Ethnicity - requested, not provided.Race - requested, not provided.Udi - not required, this product code is a bulk product.Implanted date: device was not implanted.Explanted date: device was not explanted.(b)(4).The actual device was not returned for evaluation, however a photograph of the actual sample was returned.Therefore, the investigation was based on the evaluation of user facility information, the returned photograph of the actual sample and evaluation of a retention sample from the reported product code/lot number combination.A review of the provided photo noted that the purge line tube had been fractured at the joint to the port on the oxygenator module.Visual inspection of the retention sample revealed no defects.The retention sample was built into a circuit with tubes and circulated with colored saline solution.There was no leak at the joint of the purge line tube to the port.The investigation result verified that the retention sample was the normal product with no anomaly on the purge line tube.With no return sample, the configuration of the fracture on the actual sample provided by the photograph can not be seen.From the available information, the cause of this complaint cannot be definitely determined.(b)(4).
 
Event Description
The user facility reported that during prime it was found that the purge of the oxygenator was not glued properly to the outlet.The product was changed out.It was reported that the surgery was completed successfully.No blood loss was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX 15 HOLLOW FIBER OXYGENATOR AF
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
terry callahan
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key7258703
MDR Text Key99895716
Report Number9681834-2018-00006
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial
Report Date 02/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/30/2019
Device Catalogue Number1ZZ*FX15EA
Device Lot Number161125
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/12/2018
Initial Date FDA Received02/09/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/25/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-